- Fund Type: SICAV
- Objective: Growth
- Asset Class: Equity
- Geographic Focus: Spain
Acent Europa SICAV SA
+ Add to WatchlistS0026:SM
10.89 EUR 0.000.00%As of 10:00:40 ET on 05/22/2013.
Snapshot for Acent Europa SICAV SA (S0026)
| Year To Date: | +4.09% | 3-Month: | +2.86% | 3-Year: | +3.38% | 52-Week Range: | 10.04 - 10.90 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +2.36% | 1-Year: | +7.99% | 5-Year: | +3.48% | Beta vs IBEX: | 0.38 |
Fund Profile & Information for S0026
Acent Europa SICAV SA is an open-end investment company incorporated in Spain. The investment company's objective is capital growth. It primarily invests in equity securities.
| Inception Date: | 07-27-2006 | Telephone: | 34-93-404-7700 |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | www.lacaixa.es | ||
Fundamentals for S0026
| NAV | (on 2013-05-22) 10.89 |
|---|---|
| Assets (M) | (on 2013-04-03) 10.25 |
| Fund Leveraged | N |
| Minimum Investment | - |
| Minimum Subsequent Investment | - |
Dividends for S0026
No dividends reported
Fees & Expenses for S0026
| Front Load | - |
|---|---|
| Back Load | - |
| Current Mgmt Fee | 0.55 |
| Redemption Fee | - |
| 12b1 Fee | - |
| Expense Ratio | - |
Top Fund Holdings for S0026
Filing Date: 05/31/2012| Name | Position | Value | % of Total |
|---|---|---|---|
| SPGB 4.8 01/31/24 | 1,831 | 1,589,968 | 10.242% |
| TSCOLN 5 ⅝ 09/12/12 | 500 | 535,039 | 3.446% |
| M&G Investment Funds 3 - Europ | 30,511 | 471,406 | 3.037% |
| DGELN 5 ½ 07/01/13 | 400 | 439,353 | 2.830% |
| EDF 5 ⅝ 01/23/13 | 400 | 436,543 | 2.812% |
| AUCHAN 5 04/29/13 | 400 | 429,457 | 2.766% |
| ENFP 4 ½ 05/24/13 | 400 | 429,293 | 2.765% |
| BGGRP 3 ⅜ 07/15/13 | 400 | 418,091 | 2.693% |
| Schroder International Selecti | 23,512 | 411,928 | 2.653% |
| BATSLN 3 ⅝ 06/29/12 | 400 | 405,116 | 2.610% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page